Fate Therapeutics FATE
NASDAQ FATE
$2.11 +0.02 (+0.96%)
At close: Oct 23, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Cash & Current Investments (2012 - 2026)

Updated

Fate Therapeutics (FATE) reported Cash & Current Investments of $153.8 million for Q2 2026, down 31.0% from $222.83 million a year earlier and down 12.0% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Cash & Current Investments (2012 - 2026) Analysis & Trends

At the end of FY2025, Fate Therapeutics posted Cash & Current Investments of $203.66 million, down 27.0% from FY2024.

  • Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $279.07 million in FY2024 (-11.5%), $315.18 million in FY2023 (-27.7%), $436.23 million in FY2022 (-29.2%) and $615.91 million in FY2021 (+27.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q2 2018.
  • Year over year, Cash & Current Investments has now declined in each of the last 18 quarters, with an average decline of 25.4% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 38.8%); the low point was Q1 2025 (a decline of 37.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $174.8 million (Q1 2026), $203.66 million (Q4 2025) and $215.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Fate Therapeutics 255.84 Mn 102.04 Mn - 153.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 153.80 Mn
Mar 31, 2026 174.80 Mn
Dec 31, 2025 203.66 Mn
Sep 30, 2025 215.42 Mn
Jun 30, 2025 222.83 Mn
Mar 31, 2025 240.43 Mn
Dec 31, 2024 279.07 Mn
Sep 30, 2024 296.92 Mn
Jun 30, 2024 304.88 Mn
Mar 31, 2024 383.54 Mn
Dec 31, 2023 315.18 Mn
Sep 30, 2023 349.73 Mn
Jun 30, 2023 377.94 Mn
Mar 31, 2023 408.90 Mn
Dec 31, 2022 436.23 Mn
Sep 30, 2022 505.14 Mn
Jun 30, 2022 568.85 Mn
Mar 31, 2022 573.77 Mn
Dec 31, 2021 615.91 Mn
Sep 30, 2021 678.70 Mn
API Access

Fate Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY